CCM
AMED

Catapult Capital Management’s Amedisys AMED Stock Holding History

Catapult Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$976K Sell
25,696
-34,304
-57% -$1.45M 0.37% 89
2015
Q2 		$2.38M Buy
+60,000
New +$1.87M 0.34% 100

Other funds holding AMED

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Catapult Capital Management's AMED Position: Q3 2015 in Review

Catapult Capital Management reduced its Amedisys (AMED) stake by 57% in Q3 2015, selling an estimated $1.45M and leaving 25,696 shares worth $976K. The position accounts for 0.37% of the portfolio, ranked #89.

Catapult Capital Management first reported a position in AMED in Q2 2015 and has held it in 2 quarters since. The position peaked at $2.38M in Q2 2015. 174 funds tracked by Wall St. Rank hold AMED as of Q3 2015.

  • Catapult Capital Management held 25,696 shares of Amedisys worth $976K as of Q3 2015.
  • Catapult Capital Management sold 34,304 Amedisys shares in Q3 2015, an estimated $1.45M.
  • Amedisys made up 0.37% of Catapult Capital Management's portfolio in Q3 2015, its #89 holding.
  • Catapult Capital Management first reported a position in Amedisys in Q2 2015 and has held it in 2 quarters since.
  • Catapult Capital Management's Amedisys position peaked at $2.38M in Q2 2015.
  • 174 funds tracked by Wall St. Rank held Amedisys as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.